PRTC: Portfolio advances, reduced OpEx, and robust cash position drive long-term value creation

Strong H1 2026 progress included a $260M Seaport IPO, $180M Celea financing, and Gallop's Fast Track designation. Cash burn is set to drop significantly post-Celea spin-out, with $220M in cash and a runway through 2028. Focus remains on capital efficiency and shareholder returns.

Based on PureTech Health PLC [PRTC] H1 2026 Audio Transcript — Sep. 22 2026